MoS2-x/C Nanosheets for Antifungal and Anti-Inflammatory Therapy of Aspergillus fumigatus Keratitis in Mice Authors: Zhuhui Feng, Jing Lin, Qian Wang, Lina Zhang, Lingwen Gu, Bing Yu, Xueyun Fu, Daohao Li, Guiqiu Zhao, Cui Li Published: 2025 ABSTRACT AbstractPurposeTo investigate the therapeutic potential of sulfur vacancy-molybdenum disulfide/carbon composite nanosheets (MoS2-x/C NS) in Aspergillus fumigatus (A. fumigatus) keratitis in mice.MethodsThe in vitro antifungal efficacy of MoS2-x/C NS against A. fumigatus was evaluated by propidium iodide (PI) staining, minimum inhibitory concentration (MIC) determination, and biofilm formation assays. Toxicity assessments of the MoS2-x/C NS were conducted using a Lactate dehydrogenase (LDH) assay kit for in vitro cytotoxicity and the Draize eye test for in vivo ocular irritation. The severity of fungal keratitis in mice was assessed using clinical scoring, plate counting, and hematoxylin and eosin (H&E) staining. The anti-inflammatory efficacy of MoS2-x/C NS was determined by quantifying inflammatory factor levels using reverse transcription polymerase chain reaction (RT-PCR).ResultsIn vitro, MoS2−x/C NS significantly inhibited A. fumigatus growth, demonstrated favorable biocompatibility, and reduced the expression of IL-6 and TNF-α in human corneal epithelial cells (HCECs) stimulated by inactivated A. fumigatus hyphae. In vivo, MoS2−x/C NS treatment significantly reduced fungal load, attenuated pathological corneal damage, and suppressed IL-6 and TNF-α levels, effectively alleviating A. fumigatus keratitis in mice.ConclusionThis study demonstrates that MoS2-x/C NS possesses significant therapeutic potential for fungal keratitis mediated through dual antifungal and anti-inflammatory mechanisms, thereby improving the prognosis of A. fumigatus keratitis.Keywords: MoS2−x/C NS, sulfur vacancy, Aspergillus fumigatus keratitis, antifungal, anti-inflammatory, nanomaterial therapy Introduction Fungal keratitis, a sight-threatening ocular infection, exhibits a high global incidence, accounting for 6-53% of infectious keratitis cases with >1 million annual occurrences in developing countries.1–3 The primary predisposing factors include corneal injury, prolonged contact lens wear and a medical history of systemic conditions.4 Current antifungal therapies demonstrate limited efficacy due to ocular surface physiological barriers, poor corneal drug permeability, and emerging fungal resistance.5 Recently, novel antimicrobial technologies utilizing innovative nanomaterial have emerged, offering new therapeutic avenues for fungal keratitis treatment and demonstrating potential in addressing drug resistance.6–8 Molybdenum disulfide (MoS2), a transition metal dichalcogenide, has been extensively studied due to its exceptional optical, electronic, chemical, and mechanical properties. Its substantial specific surface area and ease of functionalization have garnered significant attention in biomedical applications, positioning MoS2 as a promising nanomaterial for antimicrobial agents, biosensors, and drug delivery systems.9–12 In particular, MoS2-based nanomaterials offer a promising strategy for treating infected wounds.13,14 Recent studies further demonstrate that MoS2 exhibit antibacterial activity against both Gram-positive Staphylococcus aureus and methicillin-resistant Staphylococcus aureus (MRSA).15,16 Nevertheless, research on the antifungal properties of MoS2 with sulfur-vacancy remains limited. Currently, only a few studies suggest the potential of MoS2 in addressing fungal pathogens related to agricultural production and environmental pollution.17–21 These findings indicated that MoS2 nanoparticles could effectively inhibit the growth of Fusarium graminearum and Saccharomyces uvarum by inducing oxidative stress and cellular damage. Furthermore, this antifungal effect was enhanced by sulfur vacancies. Building on this evidence, we hypothesize that sulfur-vacancy-engineered MoS2 also acts against fungal keratitis by disrupting fungal morphology and growth. It is well-established that fungi can breach the damaged corneal epithelial barrier and invade the deeper tissues of the cornea, thereby activating local immune responses to facilitate fungal clearance.22 However, an excessive inflammatory response secondary to fungal infection can result in further damage to corneal tissue.23–25 Researches have highlighted that controlling this excessive inflammatory response is essential for improving the prognosis of fungal keratitis.26–28 Notably, MoS2 has demonstrated significant anti-inflammatory properties in models of neurological inflammation and osteoarthritis,29,30 yet its potential in treating ocular infections remains unexplored. Based on these findings, we further hypothesize that MoS2 may also exert anti-inflammatory effects in the context of fungal keratitis. In this study, we synthesized MoS2-x/C NS and evaluated its dual antifungal and anti-inflammatory properties. In vitro, the material demonstrated biocompatibility and inhibited TNF-α, IL-6, and reactive oxygen species (ROS) production in response to fungal hyphae, while also potently suppressing A. fumigatus spore germination, biofilm formation, and disrupting its cell membrane. In mice model of fungal keratitis, MoS2−x/C NS treatment markedly attenuated the infection, reducing fungal burden, corneal edema, inflammatory infiltration, and cytokine levels. The observed promotion of corneal epithelial cell migration further indicates its capacity to support healing. These findings demonstrate that MoS2-x/C NS represents a promising therapeutic strategy for fungal keratitis. Materials and Methods Materials Ammonium molybdate tetrahydrate ((NH4)6Mo7O24·4H2O), thiourea (H2NCSNH2), hydrazine hydrate solution (H4N2·H2O) and acetic acid were obtained from Sinopharm Chemical Reagent Co., Ltd. (Shanghai, China). Sodium alginate (SA) was acquired from Aladdin Reagent Co., Ltd. (Shanghai, China). Animal Experiments Female 8-week-old C57BL/6 mice were purchased from Huachuangxinnuo Co., Ltd. (Jiangsu, China). The animal experiments complied with the National Research Council’s Guide for the Care and Use of Laboratory Animals and were approved by the Ethics Committee of the Affiliated Hospital of Qingdao University (QYFYWZLL 29840). Preparation of MoS2-x/C Composite Nanomaterial The preparation schematic is illustrated in Scheme 1. Initially, ammonium molybdate tetrahydrate (0.124 g) and thiourea (0.22 g) were dissolved into 20 mL pure water. Concurrently, 0.3 mL of acetic acid and SA (0.15 g) were added to 30 mL pure water and mixed thoroughly. Subsequently, the two solutions were combined in a reaction kettle for a hydrothermal reaction at 180°C for 24 hours. Upon completion of the hydrothermal reaction, the mixture was cooled to room temperature (RT). The sample was then rinsed repeatedly with deionized water and ethanol, followed by drying in an oven at 70°C for 12 hours. After drying, the sample was naturally cooled to RT and carbonized at 800°C for 2 hours to yield the MoS2/C composite material. Finally, 3 mL of hydrazine hydrate solution was added to 100 mg of the MoS2/C composite material, and the mixture was reacted for 3 hours to produce the MoS2-x/C composite material with sulfur vacancies.31 The synthesis flowchart for MoS2-x/C NS. Characterization of MoS2-x/C Composite Nanomaterial The microstructures and morphology of the sample were investigated using transmission electron microscopy (TEM), scanning electron microscopy (SEM), high angle annular dark field scanning transmission electron microscopy (HAADF-STEM) and atomic force microscopy (AFM). The distribution of molybdenum (Mo), sulfur (S), and carbon (C) elements on the material surface was analyzed through X-ray energy dispersive spectroscopy (EDS) mapping. Additionally, the prepared materials were characterized and analyzed using electron paramagnetic resonance (EPR), X-ray diffraction (XRD), X-ray photoelectron spectroscopy (XPS) and Raman spectroscopy. Lactate Dehydrogenase (LDH) Assay of Cells The cytotoxicity of MoS2/C NS or MoS2-x/C NS to human corneal epithelial cells (HCECs) was assessed using the LDH assay. The LDH assay is a standard method for quantifying cell death, based on the measurement of LDH released from damaged cell membranes.32 Replace the culture medium containing HCECs with varying concentrations (0, 20, 40, 80, 160, and 320 µg/mL) of MoS2/C NS or MoS2-x/C NS. After co-culturing for 24 hours, utilize an LDH detection kit (Beyotime Biotechnology, Jiangsu, China) to assess the cytotoxic effects of MoS2/C and MoS2-x/C NS on HCECs by measuring the total intracellular LDH content. The experimental procedures were conducted according to the instructions provided by the reagent kit. After incubation at RT in the dark for 30 minutes, the optical density was detected at 490 nm and 600 nm, respectively. Mice’s Draize Eye Test To evaluate the impact of MoS2-x/C NS on the normal corneal epithelium in vivo, the Draize eye test was performed in mice to quantitatively assess the severity of any adverse effects.33 Healthy female C57BL/6 mice, aged eight months and exhibiting normal anterior segments, were immediately divided into two groups. The treatment complied with the ARVO Statement for the Use of Animals on Ophthalmic and Vision Research. In experimental group, 4 µL of MoS2-x/C NS (160 µg/mL) dispersion was administered to left conjunctival sac, while the control group received 4 µL of PBS solution in the same manner, four times daily. The right corneas of both groups were left untreated. On days 1, 3, and 5 post-treatment, fluorescein sodium staining was conducted on the mouse corneas using an ophthalmic slit lamp, with cobalt blue light employed to assess surface irritation of the mouse eyes. The results were recorded and evaluated according to the standards.34 The Cell Scratching Test of HCECs The cell scratch assay was performed to assess the effect of MoS2-x/C NS on the migratory ability of HCECs in vitro. Before inoculating HCECs, the bottom of each well was marked with three parallel lines in a 6-well plate using a black marker. The incubated 6-well plate was then placed in a cell culture incubator. The HCECs were cultivated until confluence reached 70% to 80%. Following this, serum-free Dulbecco’s Modified Eagle’s Medium (DMEM) cell culture medium was replaced and incubated overnight. To be specific, a 200 µL pipette tip was employed to draw three perpendicular lines across the black marker lines in each well, and the wells were washed with sterile PBS. Serum-free DMEM cell culture medium containing varying concentrations of MoS2-x/C NS (0, 80, and 160 µg/mL) was added to treat the HCECs. After 24 hours, the area of the scratch was measured to evaluate the migration ability of HCECs. Images were photographed using the EVOS™ M5000 imaging system. Calcofluor White (CFW) Staining and Minimum Inhibitory Concentration (MIC) of A. fumigatus To evaluate the antifungal activity of MoS2/C NS or MoS2-x/C NS against A. fumigatus, we employed CFW staining and MIC assays.35 A spore suspension (1 × 105 CFU/mL) was prepared, to which MoS2/C or MoS2-x/C NS were added separately. The final concentrations of the materials were adjusted to 20, 40, 80, 160, and 320 µg/mL. The mixture was thoroughly mixed and subsequently added to a 96-well plate. Initial absorbance was determined at 540 nm. The culture plate was then incubated for 24 hours, after which the absorbance was re-evaluated at the same wavelength. Then the mycelium was gently washed with sterile PBS, and 50 µL CFW staining solution was joined to each well. Images were pictured using a fluorescence inverted microscope after a 15-minute incubation in the dark. Biofilm Formation and Inhibition Test The antifungal effect was further evaluated using a biofilm formation and inhibition assay.36 MoS2-x/C NS was added to a spore suspension (1 × 105 CFU/mL), resulting in final material concentrations of 5, 10, 20, 40, 80, and 160 μg/mL. After co-culturing for 24 hours in a 24-well plate, the culture medium was discarded, and sterile PBS was used to rinse each well gently. Subsequently, the culture plate was dried at RT. The biofilm was then fixed using a glutaraldehyde solution for 20 minutes. Subsequently, 0.1% crystal violet solution was joined and allowed to stain for 15 minutes. Each well was then washed gently and repeatedly with PBS until the rinsing solution showed no discernible color. Afterward, 200 µL of 95% ethanol solution was added for decolorization. Finally, the ethanol solution was transferred to a new 96-well plate, and absorbance was observed at 570 nm. Propidium Iodide (PI) Staining PI staining was used to assess the integrity of the fungal cell membrane.37 A spore suspension of A. fumigatus (1 × 105 CFU/mL) was transferred into 6-well plates. After incubated for 24 hours, culture medium was replaced with either 160 μg/mL MoS2/C NS or MoS2-x/C NS. The plates were incubated in constant temperature incubator for an additional 24 hours. Subsequently, culture medium was discarded. Mycelium was gently washed with sterile PBS before PI staining solution was added. The plates were then incubated for 15 minutes in the dark, after which images were pictured and recorded using fluorescence inverted microscope. Mice Fungal Keratitis Models Healthy eight-month-old female C57BL/6 mice with normal anterior segments were general anesthetized. Subsequently, a deep tunnel was created within the corneal stroma at the pupillary margin on a microscope operating table. The spore suspension of A. fumigatus (1 × 107 CFU/mL) was injected using a microinjector to establish a model of A. fumigatus keratitis through the tunnel. The degree of corneal opacity in the mice was observed daily with a slit lamp, and local eye drops were administered four times a day. The experimental group received 160 μg/mL MoS2-x/C NS dispersion in the left eye, while the control group was handled with a PBS solution in the left eye. The right eyes of both groups remained untreated. Observations of corneal infection were conducted using an ophthalmic slit lamp. At 1, 3 and 5 days post-infection (p.i.), clinical scoring along with photographic documentation was performed according to the standards.38 Plate Count The fungal load in the cornea was determined by the plate counting.39 On the 3 days p.i., corneas of mice were harvested and thoroughly homogenized to produce a corneal homogenate. This homogenate was then uniformly incubated onto a solid Sabouraud culture dish. The culture dish was incubated for observation. Once surface colonies formed, photographs were taken, and the number of colonies on the surface was recorded. Inactivated A. fumigatus Stimulation HCECs were cultured until they reached 80% confluence. The culture medium was replaced and added inactivated A. fumigatus mycelium to each well to stimulate the cells for 2 hours. Subsequently, MoS2-x/C NS was added to corresponding wells, and the cells were co-cultured for an additional 6 hours. Reverse transcription polymerase chain reaction (RT-PCR) At 3 days p.i., corneas of mice were collected. Total RNA from HCECs and corneas was isolated using RNAiso Plus reagent. Then, reverse transcription was used to synthesize complementary DNA. RT-PCR was conducted following the protocols established in a prior experiment.40 The primer sequences of our experiment are detailed in Table 1. Table 1Primer SequencesGenePrimer Sequence (5’-3’)Gene Bankβ-actin (mouse)F: GATTACTGCTCTGGCTCCTAGCR: GACTCATCGTACTCCTGCTTGCNM_007393.5TNF-α (mouse)F: ACCCTCACACTCAGATCATCTTR: GGTTGTCTTTGAGATCCATGCNM_013693.3IL-6 (mouse)F: TGATGGATGCTACCAAACTGGAR: TGTGACTCCAGCTTATCTCTTGGNM_001314054.1GAPDH (human)F: TGGCACCCAGCACAATGAAR: CTAAGTCATAGTCCGCCTAGAAGCANM_001101.5IL-6 (human)F: AAGCCAGAGCTGTGCAGATGAGTAR: TGTCCTGCAGCCACTGGTTCNM_000600.5TNF-ɑ (human)F: TGCTTGTTCCTCAGCCTCTTR: CAGAGGGCTGATTAGAGAGAGGTNM_000594.4 Primer Sequences ROS Assay The ROS assay was utilized to evaluate the ROS-scavenging ability of MoS2-x/C NS.41 HCECs were incubated into a 6-well plate for 24 hours. Once a cell fusion degree of 80% was reached, the cells were pre-stimulated with inactivated A. fumigatus hyphae. After one hour of stimulation, the cells were treated with MoS2-x/C NS. After 24 hours of stimulation with inactivated A. fumigatus hyphae, H2O2 reagent was used to the normal positive control group. Experimental steps were according to the instructions of the ROS detection kit (Beyotime Biotechnology, Jiangsu, China). The negative control group received no treatment. Subsequently, the serum-free medium containing 10 μM DCFH-DA was replaced, and the plate was incubated for 30 minutes in the dark. After incubation, each well was washed with serum-free culture medium. Finally, images were pictured using the EVOS™ M5000 imaging system. Statistical Analysis GraphPad 9.0 software was performed to the analysis of the data. The data were presented as mean ± SD. One-way ANOVA was utilized for comparisons involving three or more groups. A two-tailed Student’s t-test was adopted to compare experimental data between two groups. Differences in clinical scores and CFS scores between the PBS and MoS2-x/C NS-treated groups were analyzed using two-way ANOVA. A P-value of less than 0.05 indicates that the difference is statistically significant. Each experiment was independently conducted three times. Results and Discussion Preparation and Characterization of MoS2-x/C NS MoS2/C composite material with sulfur vacancies was synthesized using hydrothermal and chemical reduction methods, as illustrated in Scheme 1. SA served as a carbon source, possessing numerous carboxyl groups that facilitated strong coordination with molybdenum atoms, thereby reducing the layered structure of MoS2. Following the removal of specific sulfur atoms from MoS2/C NS using hydrazine hydrate, MoS2-x/C NS with sulfur vacancies was produced. A dispersion of MoS2-x/C NS exhibiting good dispersibility was prepared through ultrasonic dispersion. SEM image (Figure 1A) revealed that MoS2-x/C NS possessed layered, stacked spherical structures. TEM (Figure 1B) image illustrated that the stacked spherical structures were composed of ultra-thin layers. HAADF-STEM (Figure 1C) clearly showed the existence of sulfur vacancies on the surface of MoS2-x/C NS. The AFM image (Figure 1D) indicated that the thickness of MoS2-x/C NS is less than 1.9 nm, thereby confirming the structure of MoS2-x/C NS. And HAADF-STEM (Figure 1E) image illustrated the layers of MoS2-x/C NS were curled and folded. The EDS mapping images (Figure 1F–H) revealed that the Mo, S, and C elements were uniformly distributed across the surface of MoS2-x/C NS. Additionally, the XRD spectra (Figure 1I), Raman spectra (Figure 1J), and XPS spectra (Figure 1K) exhibited characteristic peaks of MoS2, confirming that the crystal structure of the material remained unchanged during the formation of sulfur vacancies. EPR (Figure 1L) demonstrated that, in comparison to MoS2/C, the characteristic peak (g=1.928) associated with Mo-S dangling bonds in MoS2-x/C nanomaterial was intensified, signifying the formation of sulfur vacancies. This observation indicated the successful preparation of MoS2-x/C NS. Morphology, structure and characterization of MoS2-x/C NS. (A) SEM image, (B) TEM image, (C) HAADF-STEM images, the blue arrows and dashed circles represented the existence of sulfur vacancies. AFM image (D), HAADF-STEM image (E) and elemental mapping images of the MoS2-x/C NS, including Mo (F), S (G), C (H) elements. XRD patterns (I), Raman spectra (J), XPS patterns (K), and EPR (L) results of MoS2/C and MoS2-x/C NS. In vitro Antifungal Effect of MoS2-x/C NS on A. fumigatus The MIC analysis indicated that both MoS2/C NS (Figure 2A) and MoS2-x/C NS (Figure 2B) began to inhibit the sprouting of A. fumigatus spores at a concentration of 20 µg/mL, with the inhibitory effect being concentration-dependent. At concentrations below 320 µg/mL, the antifungal efficacy of MoS2-x/C NS surpassed that of MoS2/C NS (Figure 2C). CFW staining results demonstrated that, compared to the control group (Figure 2D), the fluorescence intensity of MoS2/C NS (Figure 2E) and MoS2-x/C NS (Figure 2F) treatment groups decreased, suggesting a reduction in the number of hyphae. The fluorescence intensity in the MoS2-x/C NS treatment group was weaker than MoS2/C NS, indicating a more pronounced inhibitory effect on hyphal growth. Additionally, PI staining results revealed that the fungal hyphae in the control group were almost unstained (Figure 2G). In contrast, the fungal hyphae in the 160 μg/mL MoS2/C NS (Figure 2H) and MoS2-x/C NS (Figure 2I) treatment groups exhibited red fluorescence. The MoS2-x/C NS treatment group exhibited a higher intensity of red fluorescence, indicating that this treatment resulted in more significant damage to the cell membrane and demonstrated a superior antifungal effect. As well known, biofilms significantly cause the further invasion and drug resistance of fungus; therefore, the development of drugs targeting biofilm formation may facilitate the eradication of fungal infections.42–44 We conducted crystal violet assays to evaluate the influence on the biofilm of A. fumigatus. The results indicated that MoS2-x/C NS could inhibit biofilm formation (Figure 2J) at a concentration of 160 µg/mL, suggesting that MoS2-x/C NS may reduce the drug resistance of this fungus. These results suggested that MoS2-x/C NS possessed a greater capacity to inhibit spore growth and disrupt the cell membrane of A. fumigatus. The antifungal ability of MoS2-x/C NS against A. fumigatus is stronger than that of MoS2/C NS because of the presence of sulfur vacancies. The inhibition of MoS2/C NS (A) and MoS2-x/C NS (B) on A. fumigatus spores (mean ± SD; one-way ANOVA). And the comparison (C) of MoS2/C and MoS2-x/C NS showed that the presence of sulfur vacancies enhanced antifungal ability under the concentration of 320 μg/mL (mean ± SD; two-way ANOVA). The CFW staining of hyphae demonstrated that compared to the control group (D), both MoS2/C (E) and MoS2-x/C NS (F) reduced the number of hyphae. PI staining showed that compared to the control group (G), both MoS2/C NS (H) and MoS2-x/C NS (I) treatment have increased fluorescence intensity in fungal hyphae. The crystal violet experiment (J) indicated that MoS2-x/C NS inhibits biofilm formation of A. fumigatus (mean ± SD; one-way ANOVA). Δ, referred to the change of absorbance between the 0h and 24h time points. Note: *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001. Abbreviations: ns, no significance. Toxicity Evaluation of MoS2-x/C NS on HCECs and Mouse Corneas To evaluate the biosafety of MoS2-x/C NS, we employed an LDH detection kit to assess the impact of MoS2-x/C NS on the viability of HCECs and investigated its damaging and irritating effects on mouse corneas through Draize eye toxicity experiment. In vitro, the cytotoxicity experiment indicated that the cell survival ability in the MoS2/C NS (Figure 3A) and MoS2-x/C NS (Figure 3B) treatment groups remained unaffected compared to the control group at concentrations of ≤160 µg/mL. Furthermore, the presence of sulfur vacancies did not result in increased cytotoxicity of MoS2/C NS at concentrations not exceeding 160 µg/mL (Figure 3C). In vivo, the Draize eye toxicity test involved administering MoS2-x/C NS dispersion at a concentration of 160 µg/mL to mice via eye drops for 5 days. Throughout this period, continuous dynamic observation of the mouse ocular surface was performed using ophthalmic slit lamps under cobalt blue lighting. The results demonstrated that, compared to the PBS group, MoS2-x/C NS treatment did not induce any damage to the mouse cornea. Consistent with the PBS group, the MoS2-x/C NS treatment group exhibited smooth corneal surfaces, intact corneal epithelium, and no fluorescein sodium staining (Figure 3D and E). The toxicity experiments indicated that MoS2-x/C NS at a concentration of 160 μg/mL demonstrated good biocompatibility both in vivo and in vitro, aligning with previous research.45–47 Furthermore, these results implied that sulfur vacancies enhanced the ability of MoS2/C NS to inhibit A. fumigatus without causing significant toxic effects on cells. Consequently, MoS2-x/C NS can be considered a safe, low-toxicity, and non-irritating nanomaterial for the cornea, exhibiting good biocompatibility. Moreover, 160 µg/mL was established as the safe and effective concentration of MoS2-x/C NS for subsequent biological experiments. Safety assessment of MoS2-x/C NS. The cell viability tests of MoS2/C NS (A) and MoS2-x/C NS (B) on HCECs was detected through LDH kit (mean ± SD; one-way ANOVA). The comparison (C) of MoS2-x/C NS and MoS2/C NS showed the production of sulfur vacancies does not increase the toxic effect of MoS2/C NS on HCECs at the concentration below 320 µg/mL (mean ± SD; two-way ANOVA). The toxicity of MoS2-x/C NS on mouse cornea was assessed by fluorescein staining (D). Corneal fluorescein staining (CFS) scores were evaluated (E). Note: **P < 0.01, ***P < 0.001, ****P < 0.0001. Therapeutic Effects of MoS2-x/C NS on A. fumigatus Keratitis At 1, 3 and 5 days p.i., clinical scoring of A. fumigatus keratitis of mice was performed by evaluating the area, opacity, and morphology of corneal ulcers. Our results indicated that the PBS-treated group exhibited a larger corneal ulcer area and higher opacity, accompanied by neovascularization and corneal perforation at 3 and 5 days p.i. In contrast, the MoS2-x/C NS treatment group demonstrated greater corneal transparency, reduced ulcer area, and absence of corneal neovascularization (Figure 4A). The clinical scores of keratitis in mice treated with MoS2-x/C NS were lower than those in the PBS-treated group (Figure 4B). We collected corneas from the mice at the 3 days p.i. for plate counting and HE staining. Plate counting revealed a higher number of fungal colonies cultured from the corneal homogenate of mice treated with PBS, indicating a greater residual fungal presence in the corneal tissue. Conversely, the number of fungal colonies cultured from the corneal homogenate of mice in the MoS2-x/C NS treatment group was significantly reduced, suggesting a decrease in the residual fungal count in the corneas (Figure 4C and D). As previously mentioned, the fungal load influenced fungal invasiveness.48 Our findings indicated that treatment with MoS2-x/C NS diminished the fungal load of the infected corneas, suggesting that MoS2-x/C NS inhibited further fungal invasion by reducing the residual fungal count in the corneas. HE staining (Figure 4E) indicated that in the control group, a substantial number of inflammatory cells aggregated and infiltrated in the stromal layer of the cornea, primarily concentrating at the site of the infected ulcer. In contrast, the MoS2-x/C NS treatment reduced the infiltration of inflammatory cell and improved pathological structure of A. fumigatus-infected corneas. MoS2-x/C NS improved the A. fumigatus keratitis in mice. On the 3rd and 5th days following A. fumigatus infection, the MoS2-x/C NS treatment ameliorated mouse fungal keratitis (A) and lowered clinical scores (B, mean ± SD; two-way ANOVA) compared to the PBS treatment group. Corneas were collected from mice on the 3rd day p.i. for plate colony counting and HE staining. MoS2-x/C NS treatment reduced fungal colonies numbers (C and D) in the infected corneas (mean ± SD; t-test). Furthermore, MoS2-x/C NS treatment reduced the infiltration of inflammatory cells within the infected corneal tissue, alongside alleviation of tissue edema and damage (E). Note: *P < 0.05, **P < 0.01, **** P < 0.0001. Abbreviations: ns, no significance. MoS2-x/C NS Reduced the Expression Levels of Pro-Inflammatory Factors Induced by A. fumigatus The pathophysiological process of fungal keratitis is both complex and intriguing. From the fungal perspective, spores through the damaged corneal epithelium and invade the corneal stroma through adhesion, where they germinate and produce hyphae. The proliferation of these fungal hyphae not only inflicts physical damage on the corneal structure but also generates toxic factors, including extracellular enzymes that enhance the fungi’s invasiveness. Furthermore, fungus can secrete proteases that induce the production of pro-inflammatory factors and recruit neutrophils, leading to additional tissue damage, reduced corneal transparency, and vision loss.49–52 From the host’s perspective, when fungi invade the cornea, immune cells become activated, releasing inflammatory mediators and recruiting neutrophils to eliminate the fungus. However, excessive inflammatory response can be detrimental to normal corneal tissue. If this inflammatory response is not promptly and effectively managed, it may result in permanent tissue damage to the cornea. Researches have indicated that controlling the excessive inflammatory response can be beneficial in the treatment of fungal keratitis.53–55 Therefore, it is particularly important to identify new strategies that can rapidly and effectively eradicate pathogenic fungi while minimizing excessive corneal inflammatory damage in the treatment of fungal keratitis. Therefore, we studied the anti-inflammatory properties of MoS2-x/C NS in fungal keratitis both in vitro and in vivo. Our studies indicated that after stimulated by inactivated hyphae of A. fumigatus, the expression levels of pro-inflammatory factors of HCECs were significantly elevated. However, MoS2-x/C NS treatment effectively reduced the expression of TNF-ɑ (Figure 5A) and IL-6 (Figure 5B) induced by A. fumigatus stimulation. Additionally, a study by Hua et al indicated that exposure of HCECs to Candida albicans increased ROS production, exacerbating the pathological process of fungal keratitis through oxidative stress and activation of p38/MAPK signaling pathway.56 Consequently, we proposed that ROS represented a promising target for the treatment of fungal keratitis. Nanoscale MoS2, recognized for its excellent antioxidant properties, has the capacity to scavenge various types of free radicals.57–59 Researches indicated that MoS2 could diminish the levels of pro-inflammatory factors in human bronchial cells and microglia, exhibiting remarkable antioxidant stress and anti-inflammatory protective capabilities.60–64 These findings are consistent with our research results. In our experiments, H2O2, used as a positive inducer of ROS, allows for the assessment of true intracellular ROS levels in various treatment groups by analyzing the fluorescence signal intensity from the positive control group. As illustrated in Figure 5D, the group stimulated by the inactivated mycelium of A. fumigatus showed increased ROS production and higher green fluorescence intensity in the cells surrounding the mycelium. Notably, the green fluorescence intensity in the MoS2-x/C NS treatment group decreased, indicating that MoS2-x/C NS treatment effectively mitigates excess ROS produced in HCECs stimulated by inactivated hyphae of A. fumigatus (Figure 5C). These results indicated that MoS2-x/C NS reduced ROS, thereby alleviating the oxidative stress response. In vivo, the expression of the pro-inflammatory factors IL-6 and TNF-ɑ in the corneas of fungal keratitis mice treated with PBS were significantly elevated. In contrast, the levels of IL-6 (Figure 5E) and TNF-ɑ (Figure 5F) in the MoS2-x/C NS treatment group were lower than those in PBS treatment group. MoS2-x/C NS demonstrated anti-inflammatory effects. In vitro, MoS2-x/C NS reduced the expression levels of TNF-ɑ (A) and IL-6 (B) in HCECs stimulated by inactivated mycelium of A. fumigatus (mean ± SD; one-way ANOVA). When using the fluorescent probe DCFH-A to label ROS, a substantial green fluorescence signal was tested in H2O2 positive control group (D). The fluorescence quantitative analysis ((C), mean ± SD; one-way ANOVA) showed that in comparison to normal group, HCECs stimulated by inactivated A. fumigatus exhibited an increased green fluorescence signal. However, following treatment with MoS2-x/C NS, a reduction in fluorescence signal was noted. In vivo, after 3 days of treatment with MoS2-x/C NS, the expressions of IL-6 (E) and TNF-ɑ (F) in infected corneal tissue of mice with A. fumigatus keratitis were lower than those in PBS-treated group (mean ± SD; t-test). Note: *** P < 0.001, **** P < 0.0001. Abbreviations: ns, no significance. MoS2-x/C NS Promoted Migration of HCECs In addition to exerting an antifungal effect and reducing the inflammatory response, studies have demonstrated that MoS2 possesses a notable ability to promote wound healing in infectious wounds, potentially by enhancing fibroblast migration and proliferation.65,66 The human placental amniotic membrane has extensive applications in ophthalmic surgery. Notably, a previous study showed that loading polycaprolactone (PCL) hybridized MoS2 onto decellularized human placental amniotic membrane scaffolds can reduce inflammation at the anastomotic site following colon surgery in rats, thereby promoting anastomotic healing.67 To investigate the effect of MoS2-x/C NS on corneal epithelial migration ability, we conducted scratch assays. Our results indicated that the scratch area of HCECs was significantly reduced after treatment with MoS2-x/C NS for 24 hours (Figure 6A). As shown in Figure 6B, MoS2-x/C NS treatment increased the cell migration rate, suggesting that MoS2-x/C NS treatment promotes the migration of HCECs. We believe this effect is closely associated with the presence of the molybdenum element. He et al firstly demonstrated that molybdenum-containing materials could target macrophages and exert immunomodulatory effects within the dynamic cascade of wound healing.68 Combined our experimental results, these findings supply new insights for the design of molybdenum-containing materials in tissue engineering and regenerative medicine. MoS2-x/C NS enhanced the migratory ability of HCECs. The images of the cell scratch assay (A) and the corresponding quantitative analysis ((B), mean ± SD; one-way ANOVA) showed that compared to the control group, MoS2-x/C NS significantly reduced the scratch area in a concentration-dependent. The red lines indicated the scratch edge of the HCECs when we measured the scratch distance generated by ImageJ software to measure the scratch distance. Note: **P < 0.01. Limitations and Future Perspectives Although this study demonstrates the excellent dual functionalities of MoS2-x/C NS, several limitations of the research must be acknowledged. Firstly, the current work has not yet systematically explored the impact of sulfur vacancy concentration on antifungal and anti-inflammatory capabilities. Research on bacterial keratitis has indicated that a specific density of sulfur vacancies is crucial for enhancing catalytic and antibacterial activity; however, an excess of vacancies may form charge carrier recombination centers, potentially compromising electronic properties and reducing antibacterial efficacy.69 Secondly, compared with existing literature on antimicrobial applications of MoS2 nanomaterials, previous research has predominantly focused on their intrinsic antibacterial properties, such as the inhibition of Staphylococcus aureus15 and anti-inflammatory effects70,71 of drug-loaded MoS2. Our study advances the field by constructing sulfur vacancies, which not only enhance the antifungal activity but also concurrently explore the anti-inflammatory capabilities of MoS2-x/C NS, which is a crucial combination strategy for treating fungal keratitis. Finally, further investigation and exploration in other fungal pathogens such as Candida albicans are necessary, as Candida albicans is also a major pathogen of fungal keratitis. Future research will focus on two directions: at the fundamental level, elucidating the specific molecular pathways of the antifungal and anti-inflammatory effects; and from a translational perspective, optimizing advanced delivery systems (such as thermosensitive gels) by integrating release and stability data to enhance corneal residence time and ultimately improve clinical efficacy. Conclusion Fungal keratitis remains a challenging ocular infection with limited therapeutic effect due to poor drug penetration, fungal resistance, and excessive inflammatory damage.72–74 This study demonstrates that MoS2-x/C NS, engineered with sulfur vacancies, represents an effective dual-functional nanomaterial for its management. Our findings confirmed its simultaneous antifungal activity against A. fumigatus and anti-inflammatory effects, which collectively reduced fungal load, suppressed excessive inflammation, and promoted corneal epithelial repair of A. fumigatus keratitis. The material’s capacity to address both pathogenic clearance and immune regulation underscores its therapeutic advantage. This work highlights the potential of vacancy-engineered nanomaterial as a comprehensive therapeutic strategy for fungal keratitis. Future research will focus on elucidating the detailed molecular mechanisms and optimizing delivery systems to enhance clinical translatability. Acknowledgment This work was supported by the National Natural Science Foundation of China (Nos. 81800800, 82171029 and 81870632), the Taishan Scholars Program (Nos. tsqn202103188). Disclosure The authors report no conflicts of interest in this work. References